Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zirui Lü

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry|October 14, 2025
D-DARTS: an alternative method for NaV1.5 affinity molecules identification based on dual-drug affinity responsive target stabilityZirui Lü, Xiandong Dai, Huixia Li, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging MoleculesXiaona Li, Zirui Lü, Cong Wang, et al.
European Journal of Medicinal Chemistry|April 29, 2024
Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemicsZirui Lü, Xiandong Dai, Jianjie Xu, et al.
Scientific Reports|July 16, 2025
Poneratoxin as a key tool for investigating the relationship between sodium channel hypersensitivity and impaired nerve cell functionZirui Lü, Xiandong Dai, Jianjie Xu, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Identification of Boc<sub>2</sub>Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase DegradersHui Sun, Cong Wang, Xiaona Li, et al.
European Journal of Medicinal Chemistry|March 9, 2020
Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasomeQi Sun, Tongliang Zhou, Dandan Xi, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway InhibitorsZirui Lü, Xiaona Li, Kebin Li, et al.
Biochemical Pharmacology|January 15, 2022
Nitazoxanide and related thiazolides induce cell death in cancer cells by targeting the 20S proteasome with novel binding modesZirui Lü, Xiaona Li, Kebin Li, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry|October 14, 2025
D-DARTS: an alternative method for NaV1.5 affinity molecules identification based on dual-drug affinity responsive target stabilityZirui Lü, Xiandong Dai, Huixia Li, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging MoleculesXiaona Li, Zirui Lü, Cong Wang, et al.
European Journal of Medicinal Chemistry|April 29, 2024
Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemicsZirui Lü, Xiandong Dai, Jianjie Xu, et al.
Scientific Reports|July 16, 2025
Poneratoxin as a key tool for investigating the relationship between sodium channel hypersensitivity and impaired nerve cell functionZirui Lü, Xiandong Dai, Jianjie Xu, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Identification of Boc<sub>2</sub>Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase DegradersHui Sun, Cong Wang, Xiaona Li, et al.
European Journal of Medicinal Chemistry|March 9, 2020
Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasomeQi Sun, Tongliang Zhou, Dandan Xi, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway InhibitorsZirui Lü, Xiaona Li, Kebin Li, et al.
Biochemical Pharmacology|January 15, 2022
Nitazoxanide and related thiazolides induce cell death in cancer cells by targeting the 20S proteasome with novel binding modesZirui Lü, Xiaona Li, Kebin Li, et al.
Pageof 1